Vijay Kasturi
Chief Tech/Sci/R&D Officer at CG ONCOLOGY, INC.
Net worth: 47 603 $ as of 2024-04-29
Profile
Vijay Kasturi is currently the Chief Medical Officer at CG Oncology, Inc. Prior to this, he was the Vice President-Clinical Development at AVEO Pharmaceuticals, Inc. from 2021 to 2023, the Head-Medical Affairs at EMD Serono, Inc. from 2015 to 2020, and the Senior Vice President-Scientific Affairs at FerGene, Inc. from 2020 to 2021.
Kasturi received his undergraduate degree from the University of Illinois and his doctorate from Rush Medical College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CG ONCOLOGY, INC.
0.00% | 2024-03-24 | 1,315 ( 0.00% ) | 47 603 $ | 2024-04-29 |
Vijay Kasturi active positions
| Companies | Position | Start |
|---|---|---|
| CG ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 2023-08-31 |
Former positions of Vijay Kasturi
| Companies | Position | End |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2023-07-31 |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2021-02-28 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 2020-02-29 |
Training of Vijay Kasturi
| Rush Medical College | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| Private companies | 3 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Stock Market
- Insiders
- Vijay Kasturi
